Take heed to this text

The Maestro surgical robotic. | Supply: Moon Surgical

Moon Surgical introduced right now that it raised $55.4 million and appointed a surgical robotics veteran because the chair of its board.

The French-American firm develops the Maestro system to help surgeons in comfortable tissue surgical procedures. The platform acts as a robotic surgical assistant to enhance the precision and management of laparoscopic surgical procedure.

Moon Surgical’s small, adaptable system can combine into present scientific workflows. It options capabilities that bolster working room effectivity and permits for various labor fashions.

The corporate earmarked its newest fundraising to help the continued growth and deliberate commercialization of Maestro. Moon Surgical obtained FDA 510(ok) clearance for Maestro in December 2022, adopted by CE mark final month. In June 2022, Moon Surgical accomplished a $31.3 million Collection A fundraising.

Sofinnova Companions co-led the newest funding spherical together with Nvidia’s NVentures enterprise capital arm. Dr. Fred Moll and Dr. Josh Makower participated, too. Current buyers, GT Healthcare Capital, Cathay Well being, Johnson & Johnson Innovation — JJDC and Sofinnova Companions’ MD Begin all joined. So, too, did Yann Fleureau, Siddarth Satish, Sacha Loiseau and Richard Leparmentier.

“Not even a 12 months after the final one, this new financing is extraordinarily thrilling for us, as it is going to allow us to give attention to the upcoming industrial launch of our Maestro System,” said Anne Osdoit, CEO of Moon Surgical and a associate in Sofinnova Companions’ MedTech accelerator, MD Begin. “The help of Sofinnova Companions, NVIDIA, Fred Moll, Josh Makower, and our present investor base is additional validation of the mission of Moon Surgical and the achievements of our crew.”

Huge identify in surgical robotics to chair the Moon Surgical board

With the funding, Moon Surgical introduced the appointment of Moll as an impartial chair of the board. Gérard Hascoët stays a Board Director.

“Surgical procedure by its nature entails greater than two palms,” stated Moll. “With Maestro, the surgeon can absolutely management the duties that might in any other case be accomplished by an assistant however in a way more fluid and extra handy means. It’s a functionality that has not been developed earlier than in robotic surgical procedure and delivers worth in any working room the place laparoscopy is carried out.”

Antoine Papiernik, chair of Sofinnova Companions, additionally joins the Moon Surgical board of administrators. Nvidia’s Mohamed Siddeek and Cathay Well being’s Dr. Steve Oesterle additionally be a part of as board observers. Siddeek stated Nvidia is assured in Moon Surgical’s capabilities to “ship a novel and modern answer to the market.”

“Sofinnova Companions has at all times supported formidable, world-leading, category-creating firms which ship on the promise of their distinctive expertise. Moon Surgical is a main instance,” stated Papiernik. “We imagine on this crew’s capability to convey Maestro to the market and revolutionize the surgical robotics panorama by combining their expertise and insights within the wants of the surgeon, affected person, and supplier.”